Beam Therapeutics Inc. (BEAM)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch BEAM
See up to 3 months of BEAM. The 7-day demo opens the 1M and 3M ranges and puts BEAM on your watchlist.
Start 7-day demoLatest BEAM insider trades
About Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. is an SEC registrant, filing under CIK 0001745999, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site.
BEAM Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 16,854 | $434K |
| Bona-fide gift | 1 | 123,407 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
BEAM insider transactions (Form 4)
6153 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Bethany J. Cavanagh - Officer | Open-market sale | Common Stock | 187 | $24.41 | $5K | |
| Giuseppe Ciaramella - Officer | Gift | Common Stock | 123,407 | $0.00 | - | |
| Amy Simon - Officer | Open-market sale | Common Stock | 16,667 | $25.74 footnote F2 | $429K | |
| ||||||
| Amy Simon - Officer | Open-market sale | Common Stock | 373 | $34.73 | $13K | |
| John M. Evans - Officer | Open-market sale | Common Stock | 1,900 | $34.84 footnote F5 | $66K | |
| John M. Evans - Officer | Option exercise | Stock Option (Right to Buy) | 18,663 | $0.00 | - | |
| John M. Evans - Officer | Option exercise | Stock Option (Right to Buy) | 6,337 | $0.00 | - | |
| John M. Evans - Officer | Option exercise | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| John M. Evans - Officer | Option exercise | Common Stock | 18,663 | $0.67 | $13K | |
| John M. Evans - Officer | Option exercise | Common Stock | 6,337 | $1.03 | $7K | |
| John M. Evans - Officer | Open-market sale | Common Stock | 13,421 | $35.13 footnote F2 | $472K | |
| John M. Evans - Officer | Open-market sale | Common Stock | 11,579 | $35.91 footnote F3 | $416K | |
| John M. Evans - Officer | Option exercise | Common Stock | 25,000 | $1.03 | $26K | |
| John M. Evans - Officer | Open-market sale | Common Stock | 23,100 | $34.26 footnote F4 | $791K | |
| ||||||
| FMR LLC | Open-market sale | Common Stock | 33,372 | $35.12 footnote F1 | $1.17M | |
| FMR LLC | Open-market sale | Common Stock | 251,488 | $35.26 footnote F2 | $8.87M | |
| ||||||
| Giuseppe Ciaramella - Officer | Option exercise | Common Stock | 6,505 | $0.67 | $4K | |
| Giuseppe Ciaramella - Officer | Option exercise | Common Stock | 29,000 | $1.03 | $30K | |
| Giuseppe Ciaramella - Officer | Option exercise | Stock Option (Right to Buy) | 6,505 | $0.00 | - | |
| Giuseppe Ciaramella - Officer | Option exercise | Stock Option (Right to Buy) | 29,000 | $0.00 | - | |
 Christi Shaw | Grant or award | Stock Option (Right to Buy) | 19,676 | $0.00 | - | |
 Kathleen E. Walsh | Grant or award | Stock Option (Right to Buy) | 19,676 | $0.00 | - | |
| John Maraganore | Grant or award | Stock Option (Right to Buy) | 19,676 | $0.00 | - | |
 Mark Fishman | Grant or award | Stock Option (Right to Buy) | 19,676 | $0.00 | - | |
| Chirfi Guindo | Grant or award | Stock Option (Right to Buy) | 19,676 | $0.00 | - | |
| Graham K. Cooper | Grant or award | Stock Option (Right to Buy) | 19,676 | $0.00 | - | |
| John M. Evans - Officer | Open-market sale | Common Stock | 30,078 | $24.58 | $739K | |
| Amy Simon - Officer | Open-market sale | Common Stock | 6,700 | $24.58 | $165K | |
| Bethany J. Cavanagh - Officer | Open-market sale | Common Stock | 3,242 | $24.58 | $80K | |
| Christine Bellon - Officer | Open-market sale | Common Stock | 5,956 | $24.58 | $146K | |
| Giuseppe Ciaramella - Officer | Open-market sale | Common Stock | 11,810 | $24.58 | $290K | |
| Christine Bellon - Officer | Grant or award | Common Stock | 20,000 footnote F1 | $0.00 | - | |
| ||||||
| Bethany J. Cavanagh - Officer | Grant or award | Common Stock | 20,000 footnote F1 | $0.00 | - | |
| ||||||
| Amy Simon - Officer | Grant or award | Common Stock | 31,750 footnote F1 | $0.00 | - | |
| ||||||
| Sravan Kumar Emany - Officer | Grant or award | Common Stock | 31,750 footnote F1 | $0.00 | - | |
| ||||||
| Giuseppe Ciaramella - Officer | Grant or award | Common Stock | 40,000 footnote F1 | $0.00 | - | |
| ||||||
| John M. Evans - Officer | Option exercise | Common Stock | 25,000 | $0.67 | $17K | |
| John M. Evans - Officer | Open-market sale | Common Stock | 25,000 | $22.37 footnote F2 | $559K | |
| John M. Evans - Officer | Option exercise | Common Stock | 25,000 | $0.67 | $17K | |
| John M. Evans - Officer | Open-market sale | Common Stock | 25,000 | $22.76 footnote F3 | $569K | |
| John M. Evans - Officer | Grant or award | Common Stock | 90,000 footnote F4 | $0.00 | - | |
| John M. Evans - Officer | Option exercise | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| John M. Evans - Officer | Option exercise | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| ||||||
| Giuseppe Ciaramella - Officer | Option exercise | Common Stock | 35,000 | $17.00 | $595K | |
| Giuseppe Ciaramella - Officer | Open-market sale | Common Stock | 35,000 | $32.00 footnote F2 | $1.12M | |
| Giuseppe Ciaramella - Officer | Option exercise | Stock Option (Right to Buy) | 35,000 | $0.00 | - | |
| ||||||
| Bethany J. Cavanagh - Officer | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| Giuseppe Ciaramella - Officer | Grant or award | Stock Option (Right to Buy) | 80,000 | $0.00 | - | |
| Sravan Kumar Emany - Officer | Grant or award | Stock Option (Right to Buy) | 63,500 | $0.00 | - | |
| Christine Bellon - Officer | Grant or award | Stock Option (Right to Buy) | 40,000 | $0.00 | - | |
| John M. Evans - Officer | Option exercise | Common Stock | 19,336 | $0.67 | $13K | |
| John M. Evans - Officer | Option exercise | Common Stock | 5,664 | $0.67 | $4K | |
| John M. Evans - Officer | Open-market sale | Common Stock | 16,333 | $29.19 footnote F2 | $477K | |
| John M. Evans - Officer | Open-market sale | Common Stock | 8,667 | $29.74 footnote F3 | $258K | |
| John M. Evans - Officer | Option exercise | Common Stock | 25,000 | $0.67 | $17K | |
| John M. Evans - Officer | Open-market sale | Common Stock | 22,094 | $28.27 footnote F4 | $625K | |
| John M. Evans - Officer | Open-market sale | Common Stock | 2,906 | $29.00 | $84K | |
| John M. Evans - Officer | Option exercise | Stock Option (Right to Buy) | 19,336 | $0.00 | - | |
| John M. Evans - Officer | Option exercise | Stock Option (Right to Buy) | 5,664 | $0.00 | - | |
| John M. Evans - Officer | Option exercise | Stock Option (Right to Buy) | 25,000 | $0.00 | - | |
| John M. Evans - Officer | Grant or award | Stock Option (Right to Buy) | 180,000 | $0.00 | - | |
| ||||||
Item 2.02, 9.01
Item 5.07
Item 2.02, 9.01
Item 1.02
Recent BEAM Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
BEAM insider trading FAQ
What is the latest insider trade for BEAM?
Beam Therapeutics Inc. (BEAM) had 3 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for BEAM runs to 53 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BEAM stock?
No insider purchases of BEAM were filed in the last 90 days.
How many insiders are selling BEAM stock?
2 insider sales of BEAM were filed in the last 90 days, totaling $434K.
Where can I see BEAM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BEAM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Bethany J. Cavanagh view on EDGAR
- - Giuseppe Ciaramella view on EDGAR
- - Amy Simon view on EDGAR
- - Amy Simon view on EDGAR
- - John M. Evans view on EDGAR
- - FMR LLC view on EDGAR
- - Giuseppe Ciaramella view on EDGAR
- - Christi Shaw view on EDGAR
- - Kathleen E. Walsh view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where BEAM's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BEAM with a 7-day demo
- BEAM on your watchlist
- Every BEAM Form 4 filing on record
- Up to 3 months of BEAM price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
